SCHEMBL19388239

SCHEMBL19388239

CCC(C)C(=O)C(=O)c1cccs1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.57
CES1 P23141 1/20 0.57
RAB9A P51151 6/20 0.53
NPC1 O15118 5/20 0.53
ALDH1A1 P00352 5/20 0.53
HPGD P15428 4/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
GSK3B P49841 1/20 0.49
MAPT P10636 2/20 0.48
NFKB1 P19838 1/20 0.48
NFKB2 Q00653 1/20 0.48
RELA Q04206 1/20 0.48
LMNA P02545 2/20 0.47
MEN1 O00255 1/20 0.47
POLB P06746 1/20 0.47
KMT2A Q03164 1/20 0.47
TSHR P16473 4/20 0.47
CYP2C9 P11712 3/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C19 P33261 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3197028 0.84 TSHR (0.58) CES2CES1RAB9ANPC1ALDH1A1
SCHEMBL8310773 0.82 CES2 (0.72) CES2CES1RAB9ANPC1ALDH1A1
SCHEMBL6415141 0.81 CES2 (0.55) CES2CES1RAB9ANPC1ALDH1A1
SCHEMBL14782239 0.81 CES2 (0.55) CES2CES1RAB9ANPC1ALDH1A1
SCHEMBL6410973 0.76 TSHR (0.51) CES2CES1RAB9ANPC1ALDH1A1
SCHEMBL6417954 0.76 CES2 (0.57) CES2CES1RAB9ANPC1ALDH1A1
SCHEMBL6412787 0.76 CES2 (0.52) CES2CES1RAB9ANPC1ALDH1A1
SCHEMBL1066873 0.74 CES2 (1.00) CES2CES1RAB9ANPC1ALDH1A1
SCHEMBL10031582 0.74 CES2 (0.65) CES2CES1RAB9ANPC1ALDH1A1
SCHEMBL12863468 0.73 RAB9A (0.46) CES2CES1RAB9ANPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9770439-B2 Hepatitis C virus inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2017-09-26 US disclosed